Pediatric Completed Phase 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0032563 (Pediatric)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00592111A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)Treatment